41,702 Shares in Enhabit, Inc. (NYSE:EHAB) Bought by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. bought a new position in shares of Enhabit, Inc. (NYSE:EHAB – Get Rating) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 41,702 shares of the company’s stock, valued at approximately $585,000. Raymond James Financial Services Advisors Inc. owned about 0.08% of Enhabit as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of EHAB. Strs Ohio bought a new position in shares of Enhabit during the second quarter worth $3,262,000. OLD Mission Capital LLC purchased a new stake in Enhabit during the second quarter valued at $379,000. CI Investments Inc. purchased a new stake in Enhabit during the second quarter valued at $27,000. Northern Trust Corp purchased a new stake in Enhabit during the second quarter valued at $494,000. Finally, Millennium Management LLC purchased a new stake in Enhabit during the second quarter valued at $230,000. Institutional investors own 95.55% of the company’s stock.

Wall Street Analysts Forecast Growth

EHAB has been the topic of a number of recent research reports. Stifel Nicolaus initiated coverage on shares of Enhabit in a research note on Monday, December 5th. They set a “buy” rating and a $17.00 price target on the stock. UBS Group initiated coverage on shares of Enhabit in a research note on Thursday, December 8th. They set a “sell” rating and a $12.00 price target on the stock. Oppenheimer assumed coverage on shares of Enhabit in a research note on Thursday, October 13th. They set a “market perform” rating on the stock. CJS Securities assumed coverage on shares of Enhabit in a research note on Tuesday, December 13th. They issued a “market perform” rating and a $18.00 target price on the stock. Finally, Credit Suisse Group reduced their target price on shares of Enhabit from $19.00 to $15.00 and set a “neutral” rating on the stock in a research note on Friday, November 4th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Enhabit currently has an average rating of “Hold” and an average price target of $16.43.

Insider Transactions at Enhabit

In related news, Director Jeffrey Bolton purchased 2,000 shares of the business’s stock in a transaction dated Wednesday, November 9th. The shares were purchased at an average cost of $12.75 per share, for a total transaction of $25,500.00. Following the completion of the acquisition, the director now owns 14,597 shares in the company, valued at approximately $186,111.75. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Jeffrey Bolton purchased 2,000 shares of the business’s stock in a transaction dated Wednesday, November 9th. The shares were purchased at an average cost of $12.75 per share, for a total transaction of $25,500.00. Following the completion of the acquisition, the director now owns 14,597 shares in the company, valued at approximately $186,111.75. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Gregory S. Rush bought 8,300 shares of the business’s stock in a transaction on Monday, November 7th. The shares were acquired at an average cost of $12.69 per share, for a total transaction of $105,327.00. Following the transaction, the director now directly owns 16,597 shares in the company, valued at approximately $210,615.93. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 13,000 shares of company stock worth $164,903.

Enhabit Trading Down 3.3 %

Shares of EHAB opened at $14.61 on Wednesday. Enhabit, Inc. has a twelve month low of $11.65 and a twelve month high of $25.25. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.50 and a quick ratio of 1.50. The company’s fifty day simple moving average is $13.52 and its 200-day simple moving average is $14.42.

Enhabit (NYSE:EHAB – Get Rating) last posted its quarterly earnings results on Tuesday, November 1st. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.09). The company had revenue of $265.70 million during the quarter, compared to the consensus estimate of $265.62 million. Enhabit had a return on equity of 7.62% and a net margin of 7.76%. On average, equities research analysts expect that Enhabit, Inc. will post 1.45 earnings per share for the current year.

About Enhabit

(Get Rating)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.